Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature-Reference-Cited by-同舟云学术

Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature

Published:2022-12 Issue: Volume: Page:
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Li Ye,Lv Xinna,Wang Bing,Xu Zexuan,Wang Yichuan,Sun Mengyan,Hou Dailun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference26 articles.

1. Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives;Imyanitov;Crit Rev Oncol Hematol,2021

2. Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, "uncommon-G719X, S768I, L861Q") Among the Third-Generation EGFR TKIs?;Zhang;Lung Cancer (Auckl),2022

3. Lung cancer: EGFR inhibitors with low nanomolar activity against a therapy-resistant L858R/T790M/C797S Mutant;Günther;Angew Chem Int Ed Engl,2016

4. Different clinicopathologic and computed tomography imaging characteristics of primary and acquired EGFR T790M mutations in patients with non-small-cell lung cancer;Hou;Cancer Manag Res,2021

5. Treatment of brain metastases;Matzenauer;Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma;Clinical Radiology;2024-02

2. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer;European Radiology Experimental;2024-01-02

3. Multisequence MRI-based radiomics analysis for early prediction of the risk of T790M resistance in new brain metastases;Quantitative Imaging in Medicine and Surgery;2023-12

4. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Radiology Experimental;2023-11-02